Document is current
Any future updates will be listed below
-
Authors
Faron, Matthieu https://orcid.org/0000-0003-2331-0792
Lamartina, Livia
Hescot, Segolene
Moog, Sophie
Deschamps, Frederic
Roux, Charles
Libe, Rosella
Durand-Labrunie, Jerome
Al Ghuzlan, Abir
Hadoux, Julien
Baudin, Eric
- License Information
-
More Information
Article History
Received: 28 April 2022
Accepted: 25 June 2022
First Online: 23 July 2022
Compliance with ethical standards
:
: Directly related to the present work: E.B., M.F. and R.L. have served on an advisory board for HRA Pharma. S.H. received travel grant from HRA Pharma. Not related to the present work: J.H.: Board (IPSEN, Pharma Mar, Lilly, Roche, AAA), Travel support (AAA, IPSEN), Research: (Novartis). L.L.: tumor board (IPSEN, Bayer, EISAI), Honoraria (EISAI, LILLY), Travel Grant (AAA, Novartis). S.H.: Board (Eisai, AAA), Travel support (Ipsen, AAA), Research (HRA Pharma, Ipsen). E.B.: Expert board (Ipsen, Novartis, AAA, Pfizer, Hutchinson Pharma), Research grant: (Novartis, HRA), Principal investigator (Ipsen), Drug supply (Pfizer, AAA). M.F.: Board (HRA Pharma), Honoraria (VIFOR Pharma), Travel Grant (Novartis, Ipsen).
